Platform and system for digital personalized medicine
US10839950B2 · kind B2 · utility
Assignee
Inventor
Key dates
| Filing date | Oct 9, 2018 |
| Grant date | Nov 17, 2020 |
| Priority date | — |
| Expiry date | Oct 9, 2038 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG16H80/00
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
The digital personalized medicine system uses digital data to assess or diagnose symptoms of a subject to provide personalized or more appropriate therapeutic interventions and improved diagnoses. The use of prioritized questions and answers with associated feature importance can be used to assess mental function and allow a subject to be diagnosed with fewer questions, such that diagnosis can be repeated more often and allow the dosage to be adjusted more frequently. Pharmacokinetics of the subject can be estimated based on demographic data and biomarkers or measured, in order to determine a treatment plan for the subject. Also, biomarkers can be used to determine when the patient may be at risk for experiencing undesirable side effects and the treatment plan adjusted accordingly.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.